AU2002356251A1 - 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparation and therapeutic use thereof - Google Patents
4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparation and therapeutic use thereofInfo
- Publication number
- AU2002356251A1 AU2002356251A1 AU2002356251A AU2002356251A AU2002356251A1 AU 2002356251 A1 AU2002356251 A1 AU 2002356251A1 AU 2002356251 A AU2002356251 A AU 2002356251A AU 2002356251 A AU2002356251 A AU 2002356251A AU 2002356251 A1 AU2002356251 A1 AU 2002356251A1
- Authority
- AU
- Australia
- Prior art keywords
- oxazolopyridin
- diazabicyclo
- preparation
- therapeutic use
- nonane derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0115152A FR2832714B1 (fr) | 2001-11-23 | 2001-11-23 | Derives de 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique |
FR01/15152 | 2001-11-23 | ||
PCT/FR2002/003978 WO2003044024A1 (fr) | 2001-11-23 | 2002-11-20 | Derives de 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002356251A1 true AU2002356251A1 (en) | 2003-06-10 |
Family
ID=8869704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002356251A Abandoned AU2002356251A1 (en) | 2001-11-23 | 2002-11-20 | 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparation and therapeutic use thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US7119087B2 (fr) |
EP (1) | EP1451197B1 (fr) |
JP (1) | JP5134755B2 (fr) |
AT (1) | ATE361306T1 (fr) |
AU (1) | AU2002356251A1 (fr) |
DE (1) | DE60219946T2 (fr) |
FR (1) | FR2832714B1 (fr) |
WO (1) | WO2003044024A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020086871A1 (en) | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
ATE426602T1 (de) | 2002-09-30 | 2009-04-15 | Neurosearch As | 1,4-diazabicycloalkanderivate, deren herstellung und verwendung |
EP1562945B1 (fr) * | 2002-11-11 | 2006-11-15 | Neurosearch A/S | Derives de 1,4-diazabicyclo (3,2,2)nonane, preparation et utilisations therapeutiques de ces derives |
US7223753B2 (en) | 2002-11-11 | 2007-05-29 | Neurosearch A/S | Diazabicyclic biaryl derivatives |
BRPI0506890A (pt) | 2004-02-04 | 2007-07-17 | Neurosearch As | derivado de arila diazabicìclica, composição farmacêutica, uso de um derivado de arila diazabicìclica, e, método de tratamento, prevenção ou alìvio de uma doença, distúrbio ou condição de um corpo de animal vivo |
WO2006051407A1 (fr) * | 2004-11-15 | 2006-05-18 | Pfizer Products Inc. | Azabenzoxazoles pour le traitement des troubles du systeme nerveux central |
WO2006051413A1 (fr) * | 2004-11-15 | 2006-05-18 | Pfizer Inc. | Azabenoxazoles dans le traitement des troubles du snc |
WO2006051394A1 (fr) * | 2004-11-15 | 2006-05-18 | Pfizer Products Inc. | Azabenzoxazoles pour traiter des troubles du systeme nerveux central |
WO2006051410A1 (fr) * | 2004-11-15 | 2006-05-18 | Pfizer Inc. | Azabenzoxazoles pour le traitement de troubles du systeme nerveux central |
DE602006019561D1 (de) | 2005-02-16 | 2011-02-24 | Neurosearch As | Diazabicyclische arylderivate und ihre verwendung als chinolinergische liganden an nikotin-acetylcholin-rezeptoren |
PT2889033T (pt) | 2008-11-19 | 2018-06-18 | Forum Pharmaceuticals Inc | Tratamento de sintomas negativos da esquizofrenia com (r)-7-cloro-n-(-quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida e sais farmacêuticos resultantes da mesma |
RU2011150248A (ru) * | 2009-05-11 | 2013-06-20 | Энвиво Фармасьютикалз, Инк. | Лечение когнитивных расстройств с определенными рецепторами альфа-7 никотиновой кислоты в комбинации с ингибиторами ацетилхолинэстеразы |
EP2571874B1 (fr) | 2010-05-17 | 2016-03-30 | Forum Pharmaceuticals Inc. | Forme cristalline de monohydrate d'hydrochlorure de (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide |
AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826848A (en) * | 1985-04-15 | 1989-05-02 | Janssen Pharmaceutica N.V. | Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines |
FR2786770B1 (fr) * | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
FR2809730B1 (fr) | 2000-05-31 | 2002-07-19 | Sanofi Synthelabo | Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique |
US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
-
2001
- 2001-11-23 FR FR0115152A patent/FR2832714B1/fr not_active Expired - Fee Related
-
2002
- 2002-11-20 JP JP2003545661A patent/JP5134755B2/ja not_active Expired - Fee Related
- 2002-11-20 AT AT02803450T patent/ATE361306T1/de not_active IP Right Cessation
- 2002-11-20 AU AU2002356251A patent/AU2002356251A1/en not_active Abandoned
- 2002-11-20 US US10/495,936 patent/US7119087B2/en not_active Expired - Lifetime
- 2002-11-20 DE DE60219946T patent/DE60219946T2/de not_active Expired - Lifetime
- 2002-11-20 WO PCT/FR2002/003978 patent/WO2003044024A1/fr active IP Right Grant
- 2002-11-20 EP EP02803450A patent/EP1451197B1/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2832714A1 (fr) | 2003-05-30 |
DE60219946T2 (de) | 2008-01-10 |
JP2005509681A (ja) | 2005-04-14 |
DE60219946D1 (de) | 2007-06-14 |
WO2003044024A1 (fr) | 2003-05-30 |
ATE361306T1 (de) | 2007-05-15 |
FR2832714B1 (fr) | 2004-07-16 |
JP5134755B2 (ja) | 2013-01-30 |
EP1451197B1 (fr) | 2007-05-02 |
EP1451197A1 (fr) | 2004-09-01 |
US20050004128A1 (en) | 2005-01-06 |
US7119087B2 (en) | 2006-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002356251A1 (en) | 4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-(3.2.2)nonane derivatives, preparation and therapeutic use thereof | |
WO2005049581A8 (fr) | Derives de pyridazine-3(2h)-ones et utilisation en tant qu'inhibiteurs de pde4 | |
WO2002057261A3 (fr) | Diaminothiazoles | |
AU2002246728A1 (en) | Carboline derivatives | |
EP1225173A4 (fr) | Derives de naphthyridine | |
NO20063231L (no) | Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer | |
NO20060670L (no) | N3-substituerte imidazopyridin C-kit inhibitorer | |
NO20055421L (no) | Kinolinderivater som fosfodiestrase-inhibitorer | |
WO2006065280A3 (fr) | Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole | |
AU2002310768A1 (en) | Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain | |
WO2001094345A3 (fr) | Composes chimiques | |
BRPI0510560A (pt) | pirido[2,3-d] pirimidin-7-onas pirrolil substituìdas e seus derivados como agentes terapêuticos | |
IL185611A0 (en) | Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same | |
NO20073393L (no) | [1,2,4]tnazolo [4,3-A] pyridin derivater for behandlingen av hyperproliferative sykdommer | |
WO2004018472A3 (fr) | Composes pyrimido presentant une activite antiproliferative | |
NO20062239L (no) | Nye tetrahydrospiro[piperidin-2,7'-pyrrolo[3,2-b]pyridinderivater og nye indolderivater nyttige i behandlingen av 5-HT6 reseptorrelaterte forstyrrelser | |
TW200502230A (en) | Dual nk1/nk3 derivatives | |
MXPA03012013A (es) | Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor. | |
WO2004100865A3 (fr) | Nouveaux derives de benzimidazole | |
WO2006069193A3 (fr) | Compose d'imidazo[4,5-c]pyridine et traitement antiviral dans lequel est utilise ledit compose | |
WO2000064874A3 (fr) | DERIVES DE PYRIDINE HETEROSUBSTITUES INHIBITEURS DE $i(PDE 4) | |
WO2004048328A3 (fr) | N-arylsulfonyl-3-aminoalkoxyindoles | |
WO2000059449A3 (fr) | Derives de purine possedant une activite d'inhibition de la phosphodiesterase iv | |
DE50310080D1 (de) | 3-SUBSTITUIERTE 3,4-DIHYDRO-THIENOi2,3-D PYRIMIDIN-4-ONE-DERIVATE, IHRE HERSTELLUNG UND VERWENDUNG | |
PL366858A1 (en) | Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |